Table 1 Baseline characteristics according to groups
Group I (n = 66) | Group II (n = 18) | Group III (n = 84) | p value | |
|---|---|---|---|---|
Age (years) | 51.7 ± 17.3 | 43.1 ± 14.2 | 49.7 ± 13.4 | 0.10 |
Sex, n (%) | 20 (30.3) | 3 (16.7) | 31 (36.9) | 0.23 |
Smoking, n (%) | 10 (15.2) | 3 (16.7) | 10 (11.9) | 0.79 |
Alcohol, n (%) | 18 (27.3) | 6 (33.3) | 26 (31.0) | 0.83 |
HTN, n (%) | 17 (25.8) | 4 (22.2) | 18 (21.4) | 0.82 |
DM, n (%) | 3 (4.5) | 2 (11.1) | 6 (7.1) | 0.58 |
CAD, n (%) | 1 (1.5) | 0 (0) | 0 (0) | 0.46 |
Dyslipidemia, n (%) | 30 (45.5) | 8 (44.4) | 39 (46.4) | 0.99 |
LVEF (%) | 61.7 ± 11.5 | 66.8 ± 6.9 | 61.5 ± 8.4 | 0.12 |
LA diameter (mm) | 38.8 ± 7.2 | 38.8 ± 6.1 | 37.7 ± 6.8 | 0.70 |
LA volume (mL) | 44.2 ± 15.2 | 39.7 ± 11.7 | 53.6 ± 75.1 | 0.46 |
LA volume index (mL/m2) | 27.0 ± 9.4 | 23.0 ± 6.8 | 33.0 ± 51.2 | 0.48 |
E (cm/s) | 0.70 ± 0.21 | 0.66 ± 0.17 | 0.66 ± 0.20 | 0.99 |
A (cm/s) | 0.67 ± 0.17 | 0.58 ± 0.19 | 0.66 ± 0.17 | 0.22 |
E’ (cm/s) | 0.07 ± 0.03 | 0.08 ± 0.03 | 0.75 ± 0.28 | 0.55 |
A’ (cm/s) | 0.08 ± 0.23 | 0.08 ± 0.02 | 0.10 ± 0.10 | 0.41 |
E/e’ | 10.77 ± 5.68 | 9.16 ± 3.24 | 9.68 ± 3.63 | 0.28 |
Na (mEq/L) | 137 ± 16 | 139 ± 2 | 140 ± 2 | 0.45 |
K (mEq/L) | 4.3 ± 0.4 | 4.3 ± 0.3 | 4.9 ± 4.7 | 0.55 |
Cholesterol (mg/dL) | 181 ± 37 | 170 ± 35 | 186 ± 42 | 0.35 |
BNP (pg/mL) | 56.8 ± 46.8 | 53.6 ± 70.3 | 37.2 ± 46.8 | 0.22 |
Free T4 (ng/dL) | 1.2 ± 0.2 | 1.2 ± 0.2 | 1.2 ± 0.2 | 0.89 |
TSH (μIU/mL) | 2.2 ± 1.6 | 1.9 ± 1.0 | 1.8 ± 1.7 | 0.35 |
ß-blockers medications | 0.24 | |||
Carvedilol | 12 (19.1) | 3 (21.4) | 9 (12.3) | |
Bisoprolol | 29 (46.0) | 5 (35.7) | 34 (46.6) | |
Nebivolol | 6 (9.5) | 5 (35.7) | 14 (19.2) | |
Betaxolol | 16 (25.4) | 1 (7.1) | 15 (20.5) | |
Bevantolol | 0 | 0 | 1 (1.4) |